AbCellera Biologics Inc (ABCL)
NASDAQ
The current ABCL market cap is 795.6M. The company's latest EPS is USD -0.4968 and P/E is -5.50.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | ||
Total Revenue | 10.06M | 6.6M | 9.18M | 9.95M | 7.32M |
Operating Income | -51.39M | -54.89M | -66.05M | -54.89M | -93.45M |
Net Income | -30.53M | -28.61M | -47.15M | -40.61M | -36.93M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 233.16M | 375.2M | 485.42M | 38.03M |
Operating Income | 183.17M | 249.93M | 282.95M | -237.21M |
Net Income | 118.92M | 153.46M | 158.52M | -146.4M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | ||
Total Assets | 1.54B | 1.51B | 1.49B | 1.46B | 1.41B |
Total Liabilities | 342.34M | 329.42M | 335.78M | 333.18M | 301.51M |
Total Equity | 1.19B | 1.18B | 1.15B | 1.13B | 1.11B |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 1.01B | 1.32B | 1.54B | 1.49B |
Total Liabilities | 175.03M | 292.84M | 307.63M | 335.78M |
Total Equity | 830.51M | 1.03B | 1.23B | 1.15B |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | ||
Operating | -24.16M | -24.27M | -43.88M | -41.71M | -71.67M |
Investing | -184M | -196.79M | -221.11M | 29.91M | 82.01M |
Financing | -39k | 6.59M | 10.36M | 2.83M | 5.48M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | 22.69M | 244.58M | 277.36M | -43.88M |
Investing | -119.78M | -332.25M | -352.63M | -221.11M |
Financing | 683.65M | -3.89M | -1.63M | 10.36M |
Market Cap | 795.6M |
Price to Earnings Ratio | -5.50 |
Price to Sales Ratio | 21.16 |
Price to Cash Ratio | 6.03 |
Price to Book Ratio | 0.7 |
Dividend Yield | - |
Shares Outstanding | 294.67M |
Average Volume (1 week) | 2.26M |
Average Volume (1 Month) | 2.02M |
52 Week Change | -39.19% |
52 Week High | 6.055 |
52 Week Low | 2.335 |
Spread (Intraday) | 0.12 (4.29%) |
Company Name | AbCellera Biologics Inc |
Address |
2215 yukon street vancouver, british columbia V5Y 0A1 |
Website | https://www.abcellera.com |
Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.